Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
CA to Cap Health Care Providers’ Annual Price Increases at 3% California’s Health Care Affordability Board voted to limit annual price increases from doctors, hospitals and health insurers...
VT Retailers Fight Data Privacy Bill Orvis and other online retailers based in Vermont are mounting an effort to scale back comprehensive consumer data privacy legislation ( HB 121 ) that has been passed...
Even as states are falling behind on their greenhouse gas emissions goals , that topic remains a top priority in legislatures across the country. Numerous bills have been introduced this year that would...
States Loosening Occupational Licensing Laws In an effort to boost their workforces, states are advancing legislation to loosen their occupational licensing laws. For example, the Louisiana House passed...
ME House Passes Restrictive Data Privacy Bill Maine’s House narrowly approved a bill ( LD 1977 ) that would impose restrictions on the digital information that companies can collect. Businesses...
A bill (SB 410) debated in the Michigan Senate last week would allow residents and state and local governments to sue drug manufacturers and sellers if their products cause injury. In 1995 the state passed the strongest drug immunity law in the nation, shielding drugmakers and sellers almost entirely from such suits. (BRIDGE MICHIGAN)
This year at least 24 states have enacted legislation dealing with health system consolidation and competition, according to the National Conference of State Legislatures. Among many other things the measures address the review and approval of health system mergers, reforms of health system contracting and certificate of need review. (NCSL)
California Gov. Gavin Newsom vetoed a bill (SB 90) that would have prohibited insurers from charging consumers more than $35 out of pocket for a 30-day supply of insulin. Earlier this year the governor announced the state would be partnering with the nonprofit pharmaceutical company Civica Rx to produce its own insulin, which it plans to sell for $30. (ASSOCIATED PRESS, STATE NET)
American taxpayers are overpaying for Medicare Advantage, or Medicare Part C—under which insurance companies are paid by the federal government to manage patient care—by at least $88 billion per year and possibly as much as $140 billion per year, according to a report published by Physicians for a National Health Program. “Various elements of MA, either by design or by consequence, result in a much higher level of government spending than is necessary to provide Medicare benefits, with much of this money going toward corporate profits,” the report states. (MEDICAL ECONOMICS)
—Compiled by SNCJ Managing Editor KOREY CLARK